Answers are grounded in this paper and cite their sources.
Retrospective analysis reveals regional dysregulation in neurovascular and metabolic systems in Alzheimer's disease, suggesting new diagnostic approaches.
Motivation: Alzheimer's disease (AD) is the fifth-leading cause of death in the USA, with treatment options hampered by insensitive early diagnostics. Goal(s): To develop a sensitive and stage specific diagnostic to identify regional alterations in neurovascular and metabolic regulation across the AD spectrum. Approach: Retrospective multi-modal ASL-MRI and 18F-FDG PET were assessed for regional neurovascular and metabolic dysregulation across the AD spectrum described previously1, 2. Results: AD animal models showed regional and stage dependent dysregulation1, 2, which was replicated in the current clinical study. MCI regions showed Type 1 and Type 2 uncoupling1, 2, while AD regions displayed prodromal and neuro-metabolic failure phenotypes. Impact: Early diagnosis in AD is critical to develop a prophylactic treatment strategy, minimize morbidity, and mitigating healthcare financial burden. Our novel analytical method permits early non-invasive detection of regional neurovascular and metabolic dysregulation suitable for clinical staging and enrolment.
No takes yet. Share an insight, caveat, or question.
Persohn et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: